NOTCH1 was the most frequently altered NOTCH gene in IBC (12%), whereas NOTCH2 and NOTCH4 were more frequently altered in IBC compared with non‐IBC, with a total of 12 mutations including 9 predicted as damaging. This evidence concerns the gene NOTCH4 and inflammatory breast carcinoma.